How to Break Into Regulatory Affairs Pharma US: Step-by-Step Roadmap for FMGs

If you are a Foreign Medical Graduate (FMG) living in the US, you already know that your medical degree alone is not enough to land a role in regulatory affairs. Many FMGs get stuck chasing clinical research certifications like ACRP CCRA or SoCRA CCRP, not realizing those are for clinical trial monitoring, not regulatory affairs. The real question is how to break into regulatory affairs pharma us – and that starts with understanding what FDA regulatory professionals actually do.

You deserve a clear path, not more confusion. This guide cuts through the noise. We will show you exactly what skills, tools, and steps matter for an entry-level regulatory affairs associate role in the US pharma industry – and why your international medical knowledge is an asset, not a barrier.

What does a Regulatory Affairs Associate do daily in US pharma?

When you first break into regulatory affairs pharma us as an entry-level Regulatory Affairs Associate, your day revolves around supporting the preparation, compilation, and submission of regulatory documents to the FDA. You are not writing clinical trial protocols; you are ensuring that every document meets the agency's format, content, and electronic submission standards.

Typical daily tasks include:

• Assisting with IND (Investigational New Drug) and NDA (New Drug Application) submissions
• Formatting and publishing documents using eCTD (electronic Common Technical Document) software
• Reviewing labeling, package inserts, and promotional materials for regulatory compliance
• Maintaining regulatory correspondence logs and tracking submission deadlines
• Coordinating with cross-functional teams (clinical, CMC, nonclinical) to gather required data
• Conducting regulatory intelligence research on FDA guidance and international regulations

Most work happens in document management systems and eCTD publishing tools. Employers expect you to know the difference between an IND and NDA from day one – not after six months.

What is the salary for an entry-level Regulatory Affairs Specialist in the US?

The regulatory affairs specialist salary US for entry-level roles typically ranges from $65,000 to $90,000 per year. In high-cost biotech hubs like Boston, San Diego, or the San Francisco Bay Area, you may see starting offers closer to $80,000–$95,000. In smaller markets, expect the lower end.

Key factors that influence salary:

• Geographic location (RTP in North Carolina often pays less than Boston but has lower living costs)
• Type of company (large pharma vs. small biotech vs. CRO)
• Prior exposure to regulatory submissions, even through internships or academic projects
• Certifications like RAPS RAC (although not required for entry, they can boost leverage once you have 1–2 years of experience)

Many FMGs undervalue their clinical knowledge. A candidate who can read a clinical study report and understand ICH guidelines is worth more than one who only knows formatting.

Do you need a PhD or PharmD to work in FDA Regulatory Affairs?

Absolutely not. A regulatory affairs career without PhD is very common, especially at the associate and specialist level. The minimum requirement is usually a bachelor’s degree in a life science, pharmacy, or a related field. For FMGs, your MD degree is considered equivalent to a bachelor’s plus clinical experience – sometimes even more.

Employers value practical, hands-on knowledge of the FDA IND NDA submission process and eCTD publishing more than an advanced research degree. A PhD is helpful for senior strategic roles later, but entry-level regulatory affairs is about execution, attention to detail, and regulatory writing.

Focus on building a portfolio that demonstrates you can handle an actual submission package, not just describe the theory.

Is the RAPS RAC certification required for entry-level roles?

No, the RAPS RAC certification is not required for entry-level regulatory affairs positions. Most hiring managers would rather see hands-on experience with eCTD software and a real understanding of FDA guidance than a certification obtained by memorizing regulations.

However, the RAPS RAC certification value becomes significant after 2–3 years in the field. It signals commitment and deep knowledge, and it can accelerate promotion to senior specialist or manager roles. For now, your time is better spent learning the practical tools and building a submission portfolio.

Many FMGs waste months studying for RAC when they should be learning how to publish an eCTD sequence or write a cover letter for an IND.

What is the difference between an IND and NDA submission to the FDA?

Understanding the FDA IND NDA submission process is the single most important technical knowledge for an entry-level regulatory affairs role. Here is the simple breakdown:

• IND (Investigational New Drug Application) – Filed before clinical trials can begin. It includes preclinical data, manufacturing information, and clinical protocols. The FDA reviews it to ensure patient safety. If the FDA does not object within 30 days, the trial can proceed.
• NDA (New Drug Application) – Filed after successful clinical trials to request marketing approval. It includes all clinical trial data, safety updates, proposed labeling, and manufacturing details. The FDA’s decision typically takes 6–10 months.

In daily work, you may also encounter ANDA (abbreviated NDA for generics) and BLA (Biologics License Application). All of these are submitted electronically using eCTD format, which is why eCTD publishing entry level roles are often the first step into regulatory affairs.

The Skill Gap: What Your Medical Degree Didn’t Teach You About Regulatory Affairs

As a Foreign Medical Graduate, you spent years learning diagnosis, pathology, and patient care. But regulatory affairs requires a completely different skill set – one that your medical school never covered.

Conventional education teaches:

• Clinical reasoning and disease management
• Pharmacology and therapeutics
• Research methodology (but often from an academic perspective)

Modern US pharma employers expect:

• Knowledge of 21 CFR Part 11 and ICH guidelines
• Hands-on ability to use eCTD publishing software (e.g., Lorenz, Extedo, or Veeva Vault RIM)
• Regulatory writing: how to draft module 2 summaries, cover letters, and meeting requests
• Understanding of the FDA submission lifecycle from pre-IND to post-market
• Project management and cross-functional communication

That is why a degree alone is not enough anymore. You must bridge the gap with targeted, practical training that produces verifiable work samples.

Structured Pathway: 6 Steps to Break Into Regulatory Affairs in the US

Follow this roadmap to move from confusion to clarity – and land your first regulatory affairs associate role within the next hiring cycle.

1. Unlearn clinical research certification confusion. Stop chasing ACRP CCRA or SoCRA CCRP. Those are for clinical research associates, not regulatory affairs. Redirect your energy to FDA submission knowledge.
2. Master the fundamentals of regulatory affairs. Take a structured course that covers FDA organization, IND/NDA/BLA pathways, ICH guidelines, and regulatory strategy basics. Consider our recommended roadmap: free regulatory affairs course with certificate.
3. Learn eCTD publishing hands-on. Get access to a sandbox environment or simulation where you can build a mock submission sequence. Employers want to see that you have actually used publishing tools.
4. Build a portfolio of regulatory documents. Create sample cover letters, meeting requests, and a mini eCTD table of contents. Make it publicly reviewable (e.g., a GitHub repository or a personal website).
5. Network inside the US regulatory community. Join RAPS local chapters, attend FDA public workshops, and connect with regulatory professionals on LinkedIn. Referrals matter more than cold applications. For a global perspective on regulatory affairs careers, see this handbook on starting in Europe/UK.
6. Apply for entry-level roles with a tailored resume. Highlight your FMG clinical background, your regulatory training, and your portfolio. Use keywords like 'eCTD', 'IND', 'NDA', and 'regulatory affairs' throughout your resume.

Each step builds on the previous one. Skipping the hands-on practice (step 3) is the most common reason FMGs fail to get interviews.

Simulation-Based Learning: The Bridge from Confusion to Confidence

Reading about regulatory affairs is not the same as doing it. That is why ZANE ProEd uses simulation-based learning to immerse you in real submission workflows. Instead of passively watching videos, you will work through a mock FDA submission – from drafting a regulatory strategy to publishing an eCTD sequence.

This approach gives you verifiable portfolio proof – something you can show to a hiring manager during an interview. You can say, 'I built this IND submission table of contents following ICH M4 guidelines,' rather than just 'I took a course.'

How ZANE ProEd’s Regulatory Affairs Programs Build Real Competence

Two programs form the core of the ZANE ProEd Quality & Regulatory track: the-fundamentals-of-regulatory-affairs and ectd-submission-certification. These are not generic video courses. They are practical industry training systems designed for international job aspirants like you.

The Fundamentals of Regulatory Affairs program covers the entire FDA submission landscape, including IND, NDA, ANDA, BLA, and post-market requirements. You learn how to read FDA guidance documents, write regulatory submissions, and understand ICH-GCP international compliance.

The eCTD Submission Certification is a hands-on, audit-ready simulation. You will learn how to structure documents according to the eCTD backbone, manage metadata, and publish a submission using industry-standard tools. By the end, you have a completed eCTD sequence that demonstrates your readiness for entry-level roles.

Both programs emphasize audit readiness and practical trial simulation, so you are not just memorizing regulations – you are applying them in a realistic workflow.

Audit Your Industry Readiness: Next Steps

Stop guessing and start testing your readiness. Look at a real FDA submission cover letter and ask yourself: could you write one today? If not, you know what to work on.

Explore simulation workflows, assess your current knowledge against the FDA IND NDA submission process, and identify where you need hands-on practice. The fastest way to break into regulatory affairs pharma us is to close the skill gap with targeted, portfolio-building experience.

Your medical degree gives you a strong foundation. Now add the regulatory toolkit and proof of execution – that combination is what gets you hired.